Charles River Laboratories International Inc’s recently made public that its Director WALLMAN RICHARD F unloaded Company’s shares for reported $1.43 million on Nov 07 ’24. In the deal valued at $216.12 per share,6,621 shares were sold. As a result of this transaction, WALLMAN RICHARD F now holds 12,386 shares worth roughly $2.33 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, WALLMAN RICHARD F sold 1,000 shares, generating $216,500 in total proceeds. Upon selling the shares at $216.50, the Director now owns 0 shares.
Before that, WALLMAN RICHARD F bought 12,161 shares. Charles River Laboratories International Inc shares valued at $2,626,923 were divested by the Director at a price of $216.01 per share.
CLSA upgraded its Charles River Laboratories International Inc [CRL] rating to a Hold from a an Underperform in a research note published recently. A number of analysts have revised their coverage, including CLSA’s analysts, who began to cover the stock in late October with a ‘”an Underperform”‘ rating. Redburn Atlantic began covering CRL with “Sell” recommendation on October 14, 2024. Evercore ISI revised its rating on October 07, 2024. It rated CRL as “an In-line” which previously was an “an Outperform”.
Price Performance Review of CRL
On Friday, Charles River Laboratories International Inc [NYSE:CRL] saw its stock fall -4.65% to $187.74. Over the last five days, the stock has lost -12.84%. Charles River Laboratories International Inc shares have fallen nearly -20.58% since the year began. Nevertheless, the stocks have risen 0.09% over the past one year. While a 52-week high of $275.00 was reached on 03/08/24, a 52-week low of $176.48 was recorded on 10/31/24. SMA at 50 days reached $195.26, while 200 days put it at $219.72.
Levels Of Support And Resistance For CRL Stock
The 24-hour chart illustrates a support level at 182.06, which if violated will result in even more drops to 176.38. On the upside, there is a resistance level at 194.71. A further resistance level may holdings at 201.68. The Relative Strength Index (RSI) on the 14-day chart is 43.47, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.35, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 78.97%. Stochastics %K at 38.44% indicates the stock is a holding.
How much short interest is there in Charles River Laboratories International Inc?
A steep rise in short interest was recorded in Charles River Laboratories International Inc stocks on 2024-10-31, dropping by -0.12 million shares to a total of 1.85 million shares. Yahoo Finance data shows the prior-month short interest on 2024-09-30 was 1.97 million shares. There was a decline of -6.52%, which implies that there is a negative sentiment for the stock.
